1. Home
  2. CSAI vs QNCX Comparison

CSAI vs QNCX Comparison

Compare CSAI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSAI
  • QNCX
  • Stock Information
  • Founded
  • CSAI N/A
  • QNCX 2012
  • Country
  • CSAI
  • QNCX United States
  • Employees
  • CSAI 18
  • QNCX N/A
  • Industry
  • CSAI
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CSAI
  • QNCX Health Care
  • Exchange
  • CSAI NYSE
  • QNCX Nasdaq
  • Market Cap
  • CSAI 40.8M
  • QNCX 47.7M
  • IPO Year
  • CSAI N/A
  • QNCX 2019
  • Fundamental
  • Price
  • CSAI $1.84
  • QNCX $1.31
  • Analyst Decision
  • CSAI
  • QNCX Strong Buy
  • Analyst Count
  • CSAI 0
  • QNCX 5
  • Target Price
  • CSAI N/A
  • QNCX $8.00
  • AVG Volume (30 Days)
  • CSAI N/A
  • QNCX 304.4K
  • Earning Date
  • CSAI N/A
  • QNCX 08-12-2025
  • Dividend Yield
  • CSAI N/A
  • QNCX N/A
  • EPS Growth
  • CSAI N/A
  • QNCX N/A
  • EPS
  • CSAI N/A
  • QNCX N/A
  • Revenue
  • CSAI N/A
  • QNCX N/A
  • Revenue This Year
  • CSAI N/A
  • QNCX N/A
  • Revenue Next Year
  • CSAI N/A
  • QNCX N/A
  • P/E Ratio
  • CSAI N/A
  • QNCX N/A
  • Revenue Growth
  • CSAI N/A
  • QNCX N/A
  • 52 Week Low
  • CSAI N/A
  • QNCX $0.51
  • 52 Week High
  • CSAI N/A
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • CSAI N/A
  • QNCX 64.64
  • Support Level
  • CSAI N/A
  • QNCX $1.29
  • Resistance Level
  • CSAI N/A
  • QNCX $1.45
  • Average True Range (ATR)
  • CSAI 0.00
  • QNCX 0.09
  • MACD
  • CSAI 0.00
  • QNCX 0.03
  • Stochastic Oscillator
  • CSAI 0.00
  • QNCX 76.74

About CSAI CLOUDASTRUCTURE INC

Cloudastructure Inc is engaged in cloud-based artificial intelligence (AI) video surveillance and Remote Guarding service built on AI and machine learning platforms. Its products/ services include Cloud Video Surveillance, Remote Guarding, Remote Guards, Cloud Video Recorder (CVR), Cameras and Speakers, Mobile Surveillance Trailer, etc.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: